Ketamine for Anxiety

Anxiety disorders are the most common mental health conditions in the United States, affecting over 40 million adults each year. For many, conventional treatments such as SSRIs, benzodiazepines, and therapy provide meaningful relief. But for a significant minority, anxiety persists despite multiple treatment attempts, disrupting careers, relationships, and the simple ability to feel at ease in the world.

If you have tried several medications and still find yourself trapped in cycles of worry, dread, or panic, ketamine therapy may offer a path forward. Although research for anxiety is still catching up to the robust evidence base for depression, early findings are compelling, and a growing number of clinics now treat anxiety disorders with ketamine.

Understanding Anxiety Disorders

Anxiety is a normal human emotion, an adaptive response that helped our ancestors survive real dangers. But when anxiety becomes chronic, disproportionate to actual threats, or occurs without identifiable triggers, it crosses into the territory of clinical disorder.

Types of Anxiety Disorders

Anxiety disorders encompass several distinct conditions:

• Generalized Anxiety Disorder (GAD): Persistent, excessive worry about various life domains lasting at least 6 months, often accompanied by muscle tension, restlessness, fatigue, and difficulty concentrating
• Social Anxiety Disorder (SAD): Intense fear of social situations where you might be judged, embarrassed, or scrutinized by others
• Panic Disorder: Recurrent, unexpected panic attacks characterized by rapid heart rate, shortness of breath, chest tightness, dizziness, and a feeling of impending doom
• Specific Phobias: Intense, irrational fear of particular objects or situations
• Agoraphobia: Fear of situations where escape might be difficult, often leading to avoidance of public spaces

Why Standard Treatments Fall Short for Some Patients

First-line treatments for anxiety disorders include SSRIs (sertraline, escitalopram), SNRIs (venlafaxine, duloxetine), buspirone, and cognitive behavioral therapy. Benzodiazepines (alprazolam, clonazepam) are used for short-term or acute symptom management but carry significant risks of dependence and are not recommended for long-term use.

For roughly 30-40% of patients with anxiety disorders, these standard approaches do not provide adequate relief.³ Some patients experience partial improvement but continue to have significant functional impairment. Others cannot tolerate the side effects of medications or find that the anxiety returns whenever they attempt to taper off benzodiazepines.

How Ketamine Treats Anxiety

The Glutamate-Anxiety Connection

The brain's anxiety circuitry involves a complex interplay between the amygdala (the brain's threat detection center), the prefrontal cortex (which provides rational evaluation of threats), and the hippocampus (which contextualizes threats based on memory). In anxiety disorders, the amygdala is often hyperactive, while the prefrontal cortex's ability to regulate and calm the amygdala is impaired.³

Glutamate, the brain's primary excitatory neurotransmitter, plays a central role in this circuitry. Research has shown that glutamate signaling is altered in anxiety disorders, with increased glutamate levels found in the prefrontal cortex and amygdala of anxious individuals.⁹

Ketamine's action on the glutamate system addresses these abnormalities through several pathways:

1. NMDA receptor blockade temporarily reduces excitatory signaling in overactive anxiety circuits
2. Enhanced BDNF production promotes the growth and strengthening of neural connections between the prefrontal cortex and amygdala⁶
3. Synaptic remodeling in the prefrontal cortex may restore its capacity to regulate amygdala activity
4. HPA axis modulation helps normalize the stress response system, which is often dysregulated in chronic anxiety

Neuroplasticity and Anxiety Circuit Repair

Chronic anxiety, like chronic depression, is associated with structural brain changes. The prefrontal cortex may show reduced volume and connectivity, while the amygdala may be enlarged and hyperresponsive. Ketamine's ability to rapidly promote synaptogenesis, the formation of new synaptic connections, opens what researchers sometimes call a "window of neuroplasticity."⁸

This window may be particularly valuable when combined with psychotherapy. By enhancing the brain's capacity to form new connections and overwrite maladaptive patterns, ketamine may help patients consolidate therapeutic insights from CBT or exposure therapy more effectively.

Research Evidence

The Glue 2017 Landmark Trial

The most significant controlled study of ketamine for anxiety disorders was published by Glue and colleagues in 2017. This randomized, double-blind, placebo-controlled study examined subcutaneous ketamine in 12 patients with treatment-resistant generalized anxiety disorder or social anxiety disorder.¹

Key findings:

• Dose-dependent anxiety reduction across three ascending doses (0.25, 0.5, and 1.0 mg/kg)
• Significant symptom improvement compared to placebo within hours
• Effects lasted up to 14 days from a single injection
• The 1.0 mg/kg dose produced the most robust and sustained response
• Side effects were transient and well-tolerated

While the sample size was small, this study provided crucial proof-of-concept evidence that ketamine's anxiolytic effects are real, dose-dependent, and longer-lasting than a single day.

The Taylor 2018 Case Series

Taylor and colleagues reported on a series of patients receiving repeated IV ketamine infusions for anxiety disorders resistant to standard treatment.² Their observations included:

• Significant reductions in anxiety symptom scores across multiple anxiety disorder types
• Benefits that accumulated across repeated infusions
• Improvements in both anxiety and comorbid depressive symptoms
• A treatment response pattern similar to that seen in depression studies

Comorbidity Insights

Many patients with anxiety disorders also have comorbid depression, and several studies examining ketamine for depression have included measures of anxiety. These studies consistently show that ketamine reduces anxiety symptoms alongside depression, suggesting broad effects on emotional regulation circuitry rather than a specific action limited to mood.¹⁰

Current Research Landscape

It is important to acknowledge that the evidence base for ketamine's anxiolytic effects is still developing. Compared to the extensive clinical trial data for depression (including large multicenter trials and FDA approval of Spravato), anxiety research is earlier-stage. Several larger trials are currently underway or planned.

Research gaps include:

• Optimal dosing protocols specifically for anxiety
• Long-term efficacy and safety data for anxiety-specific treatment
• Head-to-head comparisons with established anxiety treatments
• Identification of which anxiety disorder subtypes respond best

Treatment Options for Anxiety

IV Ketamine Infusions

The most common approach for treating anxiety with ketamine follows a protocol similar to depression treatment:

• Dose: 0.5 mg/kg infused over 40 minutes (some providers adjust based on response)
• Initial series: 6 infusions over 2-3 weeks
• Maintenance: Individualized based on symptom recurrence, typically every 3-6 weeks

Learn more about IV ketamine infusions

Subcutaneous Ketamine

Based on the Glue et al. research, subcutaneous injection is a viable delivery route for anxiety:

• Lower bioavailability than IV, but more practical
• Used in the key clinical trial for anxiety disorders
• Some clinics offer this as an alternative to IV infusion

Oral and Sublingual Ketamine

Sublingual ketamine tablets and troches are sometimes prescribed for anxiety management between in-clinic sessions, particularly for patients who experience breakthrough anxiety symptoms.

Important Note on Off-Label Status

All ketamine treatment for anxiety disorders is off-label. Neither racemic ketamine nor Spravato is FDA-approved for any anxiety condition. This has important implications:

• Insurance is unlikely to cover treatment for an anxiety diagnosis
• Providers should have specific experience treating anxiety with ketamine
• Informed consent should clearly state the off-label nature of treatment
• Treatment decisions should be made in the context of a comprehensive psychiatric evaluation

What to Expect During Treatment

Preparing as an Anxiety Patient

If you have an anxiety disorder, the prospect of a ketamine infusion may feel daunting. The idea of a dissociative experience can trigger anticipatory anxiety. Here are strategies that experienced clinics use to support anxious patients:

• Pre-treatment education: Knowing exactly what to expect reduces uncertainty
• Visit the clinic beforehand: Familiarize yourself with the environment before your first session
• Discuss your anxiety openly: Your provider can adjust the approach, including starting at a lower dose
• Relaxation tools: Eye masks, weighted blankets, calming playlists, and noise-canceling headphones
• Breathing techniques: Practice box breathing or 4-7-8 breathing before and during the session

During the Infusion

For patients with anxiety, it is especially important to know that the dissociative experience is temporary and medically monitored. Most patients describe the experience as dreamlike rather than frightening. Some key points:

• You will be in a safe, monitored clinical environment at all times
• A clinician can slow or pause the infusion if you experience significant distress
• The dissociative effects typically peak around 15-20 minutes into the infusion and fade within 30 minutes of completion
• Many patients with anxiety report feeling paradoxically calm during treatment

Read our complete guide to preparing for ketamine therapy

Candidate Screening and Contraindications

Ideal Candidates

Ketamine therapy for anxiety may be appropriate for:

• Adults with generalized anxiety disorder, social anxiety disorder, or panic disorder who have not responded to at least 2 adequate medication trials
• Patients with severe, functionally impairing anxiety
• Those who cannot tolerate standard anxiety medications
• Patients with comorbid depression and anxiety (strong evidence for dual benefit)

Contraindications Specific to Anxiety Patients

In addition to the standard contraindications for ketamine therapy (uncontrolled hypertension, active psychosis, unstable cardiovascular disease), anxiety patients should be aware that:

• Active benzodiazepine use may reduce ketamine's effectiveness and should be discussed with your provider
• Severe panic disorder with agoraphobia may make it difficult to attend in-clinic treatments; discuss telehealth options for monitoring between sessions
• PTSD may require a modified approach, as dissociative experiences could potentially trigger flashbacks in some individuals (though ketamine is also being studied for PTSD, as covered in our PTSD treatment guide)

Cost and Insurance

Pricing for Anxiety Treatment

Because all ketamine treatment for anxiety is off-label, costs are similar to those for depression but insurance coverage is even less likely:

• IV infusions: $400-$800 per session; 6-session series costs $2,400-$4,800
• Subcutaneous injections: $250-$500 per session (where available)
• Oral/sublingual maintenance: $100-$300 per month
• Initial consultation: $150-$350

Insurance and Payment Options

• Insurance coverage for ketamine for anxiety is currently rare
• Some patients receive coverage when anxiety is comorbid with depression and the depression diagnosis is primary
• HSA and FSA accounts can typically be used
• Many clinics offer payment plans and financing options

See our complete guide to ketamine costs

Finding a Provider for Anxiety Treatment

When seeking ketamine therapy specifically for anxiety, look for providers who:

• Have specific experience treating anxiety disorders with ketamine (not all depression-focused clinics routinely treat primary anxiety)
• Offer anxiety-informed protocols, including environmental accommodations and dose titration
• Maintain collaborative relationships with therapists for integrated treatment planning
• Provide transparent informed consent about the off-label nature of treatment and the current state of evidence

Find a ketamine clinic near you

If you are experiencing a mental health crisis, please call the 988 Suicide and Crisis Lifeline (call or text 988) or go to your nearest emergency room. Anxiety disorders are treatable conditions, and help is available.